SJS/TEN following therapy with pembrolizumab and enfortumab vedotin in a patient with urothelial carcinoma

JAAD Case Reports 2026 Open access

Read full text
Authors: Natalie Braun, Vrinda Madan, Sepideh Ashrafzadeh, Jordan Said, Vinod E. Nambudiri
DOI: 10.1016/j.jdcr.2026.02.023
Cited by: 1
References: 5

Fields of Study & Subjects

Bladder and Urothelial Cancer Treatments Hidradenitis Suppurativa and Treatments Autoimmune and Inflammatory Disorders

Publication details

Journal / source
JAAD Case Reports
Publisher
Elsevier BV
Volume
71
Pages
25–27
Publication date
18 February 2026
Language
EN